Influence
September 15, 2020

Regenstrief CEO presents on COVID-19 collaboration at Indiana CTSI annual meeting

Peter Embí presents to Indiana CTSI webinar

Regenstrief Institute President and Chief Executive Officer Peter Embí, M.D., M.S., shared the accomplishments of the Indiana Pandemic Information Collaborative (IPIC) during the annual meeting of Indiana Clinical and Translational Sciences Institute (CTSI).

IPIC is a multidisciplinary team of more than 70 members across industries and sectors with a common mission to stop the spread of COVID-19 through collaboration. IPIC activities have included data visualization, data modeling and data interchange. Notably, IPIC built the widely cited Regenstrief COVID-19 dashboard. Dr. Embí led the creation of the dashboard and this collaborative. 

Dr. Embí who also serves as the Associate Director of Informatics in the Indiana CTSI, presented as part of a panel discussion, “Indiana CTSI-enabled Therapies for Patients and the Community.” Heidi Beidinger-Burnett PhD, MPH of University of Notre Dame; Milan Radovich, PhD of Indiana University School of Medicine and Kinam Park, PhD of Purdue University also participated in the panel, which was moderated by Regenstrief research scientist and Indiana CTSI Co-director Sarah Wiehe, M.D., MPH.

Held as a webinar, the theme of the 2020 Indiana CTSI meeting was improving health from individuals to communities. It included presentations on topics such as breast cancer treatment, opioid addiction and COVID-19. The keynote was delivered by Brian Druker, M.D., director of the Knight Cancer Institute at Oregon Health & Science University. Dr Druker was presented the 2020 Gus Watanabe prize during the webinar.

Read more about Indiana CTSI’s 2020 efforts

In addition to serving as the president and CEO of Regenstrief Institute, Dr. Embí is the Leonard Betley Professor of Medicine and associate dean for informatics and health services research at Indiana University School of Medicine, associate director of informatics with Indiana Clinical and Translational Sciences Institute and vice president for Learning Health Systems with Indiana University Health.

Related News

Researchers to study online therapy’s potential to prevent cognitive decline in ICU survivors

Researchers to study online therapy’s potential to prevent cognitive decline in ICU survivors

Indianapolis – Researchers from Indiana University Indianapolis, Regenstrief Institute and the IU School of Medicine’s Indiana Alzheimer’s Disease Research

Malaz Boustani, M.D., MPH, Paul Dexter, M.D., Zina Ben Miled, PhD, M.S.

Dementia risk prediction: Zero-minute assessment at less than a dollar cost

Risk detection is important for care management and may alter course of the disease INDIANAPOLIS – A new study

Joshua Vest, PhD, MPH

Regenstrief Institute researcher appointed associate dean for research at IU Indianapolis Fairbanks School of Public Health

Regenstrief Institute Research Scientist Joshua Vest, PhD, MPH, has been appointed associate dean for research at the Indiana University

Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

Title: Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation Published in the journal JAMA Neurology. Here is